News Guided Therapeutics, Inc.

Stocks

GTHP

US40171F5017

Advanced Medical Equipment & Technology

Market Closed - OTC Markets 20:12:26 29/05/2026 +04			5-day change	1st Jan Change
0.2290 ^USD	-.--%		-8.40%	-57.59%

09-09	Guided Therapeutics, Inc. and Türkiye Ministry of Health Reach Collaborative Agreement for Primary Screening Test for Cervical Cancer	CI
08-13	Guided Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI

All News

Mentions Relevance

09-09	Guided Therapeutics, Inc. and Türkiye Ministry of Health Reach Collaborative Agreement for Primary Screening Test for Cervical Cancer	CI
09-09	Guided Therapeutics Reaches Collaborative Agreement with Türkiye’s Ministry of Health to Become Primary Screening Test for Cervical Cancer	BU
08-13	Guided Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
07-22	Guided Therapeutics Receives $80,000 Payment as Fourth Installment of $700,000 Purchase Order with Chinese Distributor	BU
07-14	Guided Therapeutics, Inc. Announces New Agreement With Yuanshuo Medical Instruments Corporation	CI
06-16	Guided Therapeutics Files Premarket Approval Application Clinical Report with FDA	CI
06-16	Guided Therapeutics Files Premarket Approval Application Clinical Report with FDA	BU
05-15	Guided Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
03-31	Guided Therapeutics Provides Updates on FDA Application Study Results, 2025 Earnings Increase and Successful Warrant Offering	BU
03-31	Guided Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025	CI
03-31	Guided Therapeutics, Inc. Auditor Raises 'Going Concern' Doubt	CI
12-17	Guided Therapeutics, Inc. Announces Preliminary Findings from Its FDA Pivotal Clinical Trial	CI
12-17	Analysis of Guided Therapeutics' FDA Study Data Reveals Compelling Clinical Need for LuViva	BU
12-11	Guided Therapeutics, Inc. Receives $88,000 Payment as Third Installment of $700,000 Purchase Order with Chinese Distributor	CI
12-11	Guided Therapeutics Receives $88,000 Payment as Third Installment of $700,000 Purchase Order with Chinese Distributor	BU
11-19	Guided Therapeutics Inks Initial $200,000 Deal with New Distribution Partner Yuanshuo Medical Instruments Corporation	CI
11-19	Guided Therapeutics Inks Initial $200,000 Deal with New Distribution Partner Yuanshuo Medical Instruments Corporation	BU
11-14	Guided Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
19/08/25	Guided Therapeutics Receives $70,000 -- Its Second of Nine Payments Totaling $700,000 -- from New Chinese Distribution Partner that Provides Products for 2 Million Annual Cervical Cancer Screenings	BU
19/08/25	Guided Therapeutics, Inc. Receives $70,000 from New Chinese Distribution Partner That Provides Products for 2 Million Annual Cervical Cancer Screenings	CI
14/08/25	Guided Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025	CI
13/08/25	Guided Therapeutics Provides Update on Completion of US FDA Clinical Trial	BU
13/08/25	Guided Therapeutics Provides Update on Completion of US FDA Clinical Trial	CI
02/07/25	Guided Therapeutics Makes Initial Shipment to New Chinese Distribution Partner Hangzhou Dongye Medical Technology, Ltd	CI
02/07/25	Guided Therapeutics Makes Initial Shipment to New Chinese Distribution Partner Hangzhou Dongye Medical Technology, Ltd.	BU